MRK DMA

As of date:	2/6/2023
MRK stock price:	104.03
MRK 50 DMA:	109.32
MRK 200 DMA:	94.69
MRK MACD (200-50):	-14.63

Also see:
MRK Market Cap History
MRK Shares Outstanding History
MRK YTD Return
MRK RSI
MRK MACD
MRK Technical Analysis

Predict charts, win cash @ chartsweeps.com

Trupanion (TRUP) Shares Cross Below 200 DMA
1 hour, 20 minutes ago

CHS Breaks Below 200-Day Moving Average - Notable for CHSCM
1 hour, 20 minutes ago

NUVA Makes Notable Cross Below Critical Moving Average
1 hour, 23 minutes ago

PRTS Crosses Below Key Moving Average Level
1 hour, 23 minutes ago

Mesa Laboratories (MLAB) Shares Cross Below 200 DMA
1 hour, 30 minutes ago

Notable Two Hundred Day Moving Average Cross - ENFN
1 hour, 36 minutes ago

BlackRock Municipal Target Term Trust Breaks Below 200-Day Moving Average - Notable for BTT
1 hour, 43 minutes ago

First Trust Dorsey Wright Dynamic Focus 5 (FVC) Shares Cross Below 200 DMA
1 hour, 43 minutes ago

FCTR Crosses Below Key Moving Average Level
1 hour, 56 minutes ago

Notable Two Hundred Day Moving Average Cross - AVY
1 hour, 56 minutes ago

Cohen & Steers Total Return Realty Fund (RFI) Shares Cross Below 200 DMA
1 hour, 56 minutes ago

Notable Two Hundred Day Moving Average Cross - VBND
2 hours ago

Loblaw Companies (L.CA) Shares Cross Above 200 DMA
2 hours, 4 minutes ago

Sonos Inc Breaks Below 200-Day Moving Average - Notable for SONO
4 hours, 28 minutes ago

The Trade Desk Breaks Below 200-Day Moving Average - Notable for TTD
4 hours, 30 minutes ago

More Technical Analysis News

MRK DMA

MRK MACD

Merck & Co. is a global health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. Co.'s reportable segments are: the Pharmaceutical and Animal Health. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures and markets a range of veterinary pharmaceuticals, vaccines and health management solutions and services, as well as a suite of digitally connected identification, traceability and monitoring products.

When researching a stock like Merck, many investors are the most familiar with Fundamental Analysis — looking at a company's balance sheet, earnings, revenues, and what's happening in that company's underlying business. Investors who use Fundamental Analysis to identify good stocks to buy or sell can also benefit from MRK Technical Analysis to help find a good entry or exit point. Technical Analysis is blind to the fundamentals and looks only at the trading data for MRK stock — the real life supply and demand for the stock over time — and examines that data in different ways. One of those ways is to calculate a Simpe Moving Average ("SMA") by looking back a certain number of days. One of the most popular "longer look-backs" is the MRK 200 day moving average ("MRK 200 DMA"), while one of the most popular "shorter look-backs" is the MRK 50 day moving average ("MRK 50 DMA"). A chart showing both of these popular moving averages is shown on this page for Merck.

10 Most Oversold S&P 500 Stocks

10 Most Overbought S&P 500 Stocks

10 ETFs With Stocks Insiders Are Buying

10 ETFs With Most Upside To Targets

The DividendRank Top 25

Warren Buffett Dividend Stocks

10 Cheap Dividend Stocks Under $10

10 Top DividendRank'ed Energy Stocks

The 10 Highest Yielding Preferred Stocks

The 15 Most Active S&P Call & Put Options

Quotes delayed 20 minutes

Free MRK Email Alerts:
Get Dividend Alerts

Get SEC Filing Alerts

Video: Technical Analysis

If the video does not load after a few moments, Upgrade to the Latest Flash Player.

Merck (MRK) is categorized under the Healthcare sector; to help you further research DMA, below are some other companies in the same sector:

MRNA DMA
OGN DMA
PFE DMA
PKI DMA
REGN DMA
RMD DMA
STE DMA
SYK DMA
TECH DMA
TFX DMA
More Healthcare companies »

MRK DMA | www.StockDMA.com | Copyright © 2019 - 2023, All Rights Reserved

Nothing in StockDMA.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.